Literature DB >> 16819328

Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.

Bonnie L Balzer1, Thomas M Ulbright.   

Abstract

Spontaneous regression of testicular germ cell tumors (GCTs) is a well-recognized phenomenon but has been incompletely characterized. Many pathologists are not familiar with the findings that support a diagnosis of a "burnt-out" primary in a patient with metastatic GCT. We therefore report the clinical, gross, and histologic findings in 42 cases of testicular GCT that showed either complete (26) or greater than 50% scarring (16). Thirty-seven patients (88%) had either known GCT metastasis or some residual testicular GCT, and none had treatment before orchiectomy. The patients were 17 to 67 years old, with a median of 32. Thirty presented with symptoms of metastasis, 7 with a testicular mass, 2 with elevated human chronic gonadotropin, and 1 with testicular pain. In 2 patients the presentation was unknown. Two patients had prior orchiopexy; another had an intraabdominal testis, and 2 others had prior contralateral seminoma (20 and 42 years previously). Gross descriptions in 37 cases identified white to tan scars, 0.6 to 2.4 cm, in 33. These were circumscribed in 16, with 15 of these having nodular or multinodular configurations and 1 a band-like appearance. In 9 cases the scar was ill defined or stellate, and in 8 cases no further details concerning the scar configuration were available. In 4 cases no scar was apparent; 2 of these had received intraoperative biopsy. Microscopically, all cases showed circumscribed to irregular foci of scarring, distinct from the adjacent parenchyma, in association with widespread testicular atrophy. Other common features were lymphoplasmacytic infiltrates in the scars (37/42) and "ghost" tubules in scars (31/42). Less common features in the scars included angiomatous foci (22/42), siderophages (15/42), and coarse intratubular calcifications (6/42); in the surrounding testis they included intratubular germ cell neoplasia, unclassified (IGCNU) (22/42), Leydig cell prominence (18/42), and necrosis (5/42). Tubular microliths occurred in 13 cases, 12 peripheral to the scar and 1 within it. Metastases in 31 cases were: pure seminoma (17, 3 with residual testicular seminoma), mixed GCT with seminoma (4, 3 with residual testicular seminoma), mixed nonseminomatous GCT (4, 3 with residual testicular GCT), pure embryonal carcinoma (2), pure teratoma (2, 1 with residual testicular teratoma), and pure yolk sac tumor (2). In 5 cases with clinically diagnosed metastases, there was no histologic documentation of the nature of the metastatic tumor. Testicular tumors in the remaining 6 cases having residual primaries without concomitant metastases were pure seminoma (3), mixed GCT with seminoma (2), and pure embryonal carcinoma (1). The most specific histologic findings of a regressed GCT are a distinct scar in association with either IGCNU or coarse intratubular calcifications; however, many cases lack the latter 2 features. In such cases additional features supportive of regressed GCT include testicular atrophy, microlithiasis and, in the scar, lymphoplasmacytic infiltrates and prominent vascularity. Ghost tubules in many scars are not evidence of a non-neoplastic process but likely reflect regression of tumors with intertubular growth. Intertubular growth is a common finding in seminoma, which is the single most frequent type of regressed GCT, occurring either in pure or mixed form in the metastases of 68% (21/31) of the cases and identifiable in 62% (10/16) of persistent testicular tumors. We conclude that regression of testicular GCTs shows a distinctive constellation of findings that usually permits its recognition. In contrast, nonspecific atrophy lacks distinct scars, and scars from non-neoplastic causes lack most of the associated findings seen in our cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819328     DOI: 10.1097/01.pas.0000209831.24230.56

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  28 in total

1.  Spontaneous regression of malignant tumors: Importance of the immune system and other factors (Review).

Authors:  Sante Basso Ricci; Ugo Cerchiari
Journal:  Oncol Lett       Date:  2010-09-23       Impact factor: 2.967

2.  Case - Confirmed testicular mass on ultrasound with no evidence on histology in two teenagers.

Authors:  Sarah Emilie Lebel; Stéphane Bolduc; Katherine Moore
Journal:  Can Urol Assoc J       Date:  2019-09-27       Impact factor: 1.862

3.  Adult metastatic yolk sac tumor descending from an intra-abdominal testis: A case report and review of the literature.

Authors:  Zhao Wang; Bin Yan; Yong-Bao Wei; Zhuo Yin; Ke-Qin Zhou; Jin-Rui Yang
Journal:  Oncol Lett       Date:  2015-10-20       Impact factor: 2.967

4.  Mediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases.

Authors:  Alejandro Luiña Contreras; Metin Punar; Pheroze Tamboli; Shi-Ming Tu; Louis Pisters; Cesar Moran; Bogdan A Czerniak; Charles C Guo
Journal:  Hum Pathol       Date:  2010-02-12       Impact factor: 3.466

Review 5.  Morphological approach to tumours of the testis and paratestis.

Authors:  Robert E Emerson; Thomas M Ulbright
Journal:  J Clin Pathol       Date:  2007-02-16       Impact factor: 3.411

6.  Regression of metastatic seminoma in a patient referred for carcinoma of unknown primary origin.

Authors:  John E Musser; Christopher G Przybycin; Paul Russo
Journal:  Nat Rev Urol       Date:  2010-07-06       Impact factor: 14.432

7.  Primary choriocarcinoma of the liver: a clinicopathological study of five cases in males.

Authors:  Huaiyin Shi; Dengfeng Cao; Lixin Wei; Lu Sun; Aitao Guo
Journal:  Virchows Arch       Date:  2009-12-16       Impact factor: 4.064

Review 8.  Why does cytotoxic chemotherapy cure only some cancers?

Authors:  Philip Savage; Justin Stebbing; Mark Bower; Tim Crook
Journal:  Nat Clin Pract Oncol       Date:  2008-11-04

Review 9.  [Testicular seminomas. The classical and the less classical ones].

Authors:  P K Bode; H Moch
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

10.  Metastatic seminoma presenting as flank pain.

Authors:  Lisa G Smyth; Niall F Davis; James C Forde; Olive O'Kelly; Rrajnish K Gupta; Hugh Flood
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.